| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |